These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24028581)

  • 1. Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug.
    Lee YK; Choi J; Wang W; Lee S; Nam TH; Choi WS; Kim CJ; Lee JK; Kim SH; Kang SS; Khang D
    ACS Nano; 2013 Oct; 7(10):8484-97. PubMed ID: 24028581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugs.
    Chen A; Xu C; Li M; Zhang H; Wang D; Xia M; Meng G; Kang B; Chen H; Wei J
    Sci Rep; 2015 Oct; 5():15527. PubMed ID: 26483341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
    Chaudhuri P; Soni S; Sengupta S
    Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional branched gold-carbon nanotube hybrid for cell imaging and drug delivery.
    Minati L; Antonini V; Dalla Serra M; Speranza G
    Langmuir; 2012 Nov; 28(45):15900-6. PubMed ID: 23083447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
    Datir SR; Das M; Singh RP; Jain S
    Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
    Patel KJ; Trédan O; Tannock IF
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
    Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
    Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
    Hu K; Zhu L; Liang H; Hu F; Feng J
    Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
    Mehra NK; Jain NK
    J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
    Hong RL; Tseng YL
    Cancer; 2001 May; 91(9):1826-33. PubMed ID: 11335910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
    van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
    FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.
    Murakami T; Sawada H; Tamura G; Yudasaka M; Iijima S; Tsuchida K
    Nanomedicine (Lond); 2008 Aug; 3(4):453-63. PubMed ID: 18694307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
    Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
    Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible dispersions of carbon nanotubes: a potential tool for intracellular transport of anticancer drugs.
    Di Crescenzo A; Velluto D; Hubbell JA; Fontana A
    Nanoscale; 2011 Mar; 3(3):925-8. PubMed ID: 21180768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
    Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A
    Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Etrych T; Chytil P; Pechar M; Jelinkova M; Rihova B
    Int J Pharm; 2004 Jun; 277(1-2):63-72. PubMed ID: 15158969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
    Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
    Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.